Dormonoct, Tabletten Uses, Dosage, Side Effects and more
Dormonoct, Tabletten is an imidazobenzodiazepine with anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. It is indicated for the short-term treatment of insomnia including difficulty in falling asleep and/or frequent nocturnal awakenings. Dormonoct, Tabletten is recommended as a short-term therapy only, due to adverse events associated with the drug including dependence and withdrawal symptoms. It is a positive modulator of GABA-A receptor that enhances the inhibitory neurotransmission. It is not an FDA-approved drug.
| Trade Name | Dormonoct, Tabletten |
| Generic | Loprazolam |
| Loprazolam Other Names | Loprazolam, Triazulenone |
| Type | |
| Formula | C23H21ClN6O3 |
| Weight | Average: 464.904 Monoisotopic: 464.136366275 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | Sanofi |
| Available Country | Netherlands |
| Last Updated: | January 7, 2025 at 1:49 am |
